Jo Vandervoort unit coordinator

Research Jo Vandervoort

Research team

Development and optimization of biocompatible colloidal carriers (liposomes and nanoparticles) for targeting the intracellular parasite Leishmania donovani. 01/05/2005 - 31/12/2006

Abstract

The research consists of the formulation and optimalisation of colloidal carriers (liposomes and nanoparticles) in order to target leishmania parasites in the host cells with a broad spectrum and potent saponine. The influence of the technological parameters of the preparation procedure on the physicochemical properties and the endocytosis of the carriers will be investigated. The therapeutic effect in vitro and in vivo will be evaluated.

Researcher(s)

Funding

  • BOF

Project type(s)

  • Research Project

Supramolecular drug carrier systems for ophthalmic use. 01/10/2000 - 30/09/2002

Abstract

The aim of the project is to develop and characterize carrier systems made of bio-compatible polymers. To improve the bioavailability of ophthalmic drugs, combination of following mechanisme will be used = muco- or/and bioadhesion, endocytosis of the carrier and penetration enhancing of the drug.

Researcher(s)

Funding

  • FWO

Project type(s)

  • Research Project

Supramolecular drug carrier systems for ophthalmic use. 01/10/1998 - 30/09/2000

Abstract

The aim of the project is to develop and characterize carrier systems made of bio-compatible polymers. To improve the bioavailability of ophthalmic drugs, combination of following mechanisme will be used = muco- or/and bioadhesion, endocytosis of the carrier and penetration enhancing of the drug.

Researcher(s)

Funding

  • FWO

Project type(s)

  • Research Project

Supramolecular drug carrier systems for ophthalmic use. 01/10/1997 - 30/09/1998

Abstract

The aim of the project is to develop and characterize carrier systems made of bio-compatible polymers. To improve the bioavailability of ophthalmic drugs, combination of following mechanisme will be used = muco- or/and bioadhesion, endocytosis of the carrier and penetration enhancing of the drug.

Researcher(s)

Funding

  • BOF

Project type(s)

  • Research Project